Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. N Engl J Med. 2016 Jul 28; 375(4):345-56.

View in: PubMed